BioSpace News Archive

Translate Bio today announced that it has launched an initial public offering of 7,700,000 shares of its common stock.

Gamida Cell announced that preliminary data from an ongoing phase I study from the nicotinamide-based natural killer cell expansion, or NAM-NK, program will be presented during the Inaugural AACR International Meeting on Advances in Malignant Lymphoma

Health Catalyst has been named a 2018 Best Places to Work in IT by IDG’s Computerworld for the second year in a row.

Big data-driven software platform reduces the time from experiment design to discovery through analysis and visualization of -omics drug discovery data.

Eyecarrot Innovations Corp is pleased to announce its participation at the 8th International Congress of Behavioural Optometry (“ICBO”) held at the International Convention Centre Sydney

Agreement with Glooko Provides Broad Access of Insulin Pump Therapy Optimization to Physicians, Patients and Payers

Customizing nutrition plans to an individual’s genetic makeup can offer members even greater personalization for weight loss and overall wellness

Medal Recognizes Organizations That Reflect Company’s Commitment to Expanding Access to Care for People and Animals in Need

Dr. Schmidt comes to Allogene from Cowen and Company, where he served as Managing Director and Senior Biotechnology Analyst since 1998

The designation is for the treatment of patients with medium to high folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer who received at least one, but no more than three prior systemic treatment regimens, and for whom single-agent chemotherapy is appropriate as the next line of therapy.